Clinical Trials
New Data from Phase IIIb Study Reinforces Safety Profile of Roche’s Hemlibra in People with Haemophilia A
Roche
PR-M07-20-NI-020Jul 13, 2020
Diagnostics
Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home
Takeda
PR-M12-19-NI-009Dec 6, 2019
Clinical Trials
uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B
uniQure
PR-M09-19-NI-013Sep 6, 2019
Drug Approval
BioMarin Going for 2020 Approval of its Hemophilia A Gene Therapy
Pharma's Almanac
PAO-M08-19-NI-026Aug 22, 2019
Recall
Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States
Nice Insight
PR-M07-19-NI-062Jul 24, 2019
Hematology/Oncology
Blood Cancer Therapeutics: Global Markets to 2023
ReportLinker
PR-M01-19-NI-034Jan 11, 2019
Drug Development
Bayer Gets FDA Approval for Hemophilia A Drug
Emilie Branch
Pharma's Almanac
PAO-M09-18-NI-006Sep 6, 2018
Clinical Trial
Sangamo Announces Positive Preliminary Data from the Phase 1/2 Alta Study Evaluating SB-525 Gene Therapy for Hemophilia A
Sangamo Therapeutics
PR-M08-18-NI-113Aug 29, 2018
Cell and Gene Therapy
Shire Submits IND for Hemophilia A Gene Therapy
Nigel Walker
Nice Insight
PAO-M07-17-NI-016Jul 13, 2017